Cargando…
Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction
BACKGROUND: The aim of this study was to evaluate the feasibility of liver resection in hepatocellular carcinoma (HCC) patients with preoperative renal dysfunction (RD). METHODS: Data from 735 patients undergoing primary liver resection for HCC between 2002 and 2014 were analyzed. Short- and long-te...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101999/ https://www.ncbi.nlm.nih.gov/pubmed/29947980 http://dx.doi.org/10.1007/s00268-018-4698-3 |
_version_ | 1783511733460008960 |
---|---|
author | Shirata, Chikara Hasegawa, Kiyoshi Kokudo, Takashi Yamashita, Suguru Yamamoto, Satoshi Arita, Junichi Akamatsu, Nobuhisa Kaneko, Junichi Sakamoto, Yoshihiro Kokudo, Norihiro |
author_facet | Shirata, Chikara Hasegawa, Kiyoshi Kokudo, Takashi Yamashita, Suguru Yamamoto, Satoshi Arita, Junichi Akamatsu, Nobuhisa Kaneko, Junichi Sakamoto, Yoshihiro Kokudo, Norihiro |
author_sort | Shirata, Chikara |
collection | PubMed |
description | BACKGROUND: The aim of this study was to evaluate the feasibility of liver resection in hepatocellular carcinoma (HCC) patients with preoperative renal dysfunction (RD). METHODS: Data from 735 patients undergoing primary liver resection for HCC between 2002 and 2014 were analyzed. Short- and long-term outcomes were compared between the RD group, defined by a preoperative estimated glomerular filtration rate of <45 mL/min/1.73 m(2), and the non-RD group. RESULTS: Sixty-two patients had RD. The incidence of postoperative pleural effusion (24 vs. 11%; P = 0.007) and major complications (Clavien–Dindo III–V; 31 vs. 15%; P = 0.003) were significantly higher in RD patients. In RD patients with Child-Pugh A, 90-day mortality rate (1.9%) and median survival time (6.11 years) were comparable to that of non-RD patients. In contrast, RD patients with Child-Pugh B had a very high 90-day mortality rate (22.2%), and a significant shorter median survival time compared to non-RD patients (1.19 vs. 4.84 years; P = 0.001). CONCLUSIONS: Liver resection for Child-Pugh A patients with RD is safe and has comparable oncological outcomes compared to non-RD patients. However, selection of liver resection candidates from Child-Pugh B patients with RD should be stricter. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00268-018-4698-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7101999 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-71019992020-03-31 Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction Shirata, Chikara Hasegawa, Kiyoshi Kokudo, Takashi Yamashita, Suguru Yamamoto, Satoshi Arita, Junichi Akamatsu, Nobuhisa Kaneko, Junichi Sakamoto, Yoshihiro Kokudo, Norihiro World J Surg Original Scientific Report BACKGROUND: The aim of this study was to evaluate the feasibility of liver resection in hepatocellular carcinoma (HCC) patients with preoperative renal dysfunction (RD). METHODS: Data from 735 patients undergoing primary liver resection for HCC between 2002 and 2014 were analyzed. Short- and long-term outcomes were compared between the RD group, defined by a preoperative estimated glomerular filtration rate of <45 mL/min/1.73 m(2), and the non-RD group. RESULTS: Sixty-two patients had RD. The incidence of postoperative pleural effusion (24 vs. 11%; P = 0.007) and major complications (Clavien–Dindo III–V; 31 vs. 15%; P = 0.003) were significantly higher in RD patients. In RD patients with Child-Pugh A, 90-day mortality rate (1.9%) and median survival time (6.11 years) were comparable to that of non-RD patients. In contrast, RD patients with Child-Pugh B had a very high 90-day mortality rate (22.2%), and a significant shorter median survival time compared to non-RD patients (1.19 vs. 4.84 years; P = 0.001). CONCLUSIONS: Liver resection for Child-Pugh A patients with RD is safe and has comparable oncological outcomes compared to non-RD patients. However, selection of liver resection candidates from Child-Pugh B patients with RD should be stricter. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00268-018-4698-3) contains supplementary material, which is available to authorized users. Springer International Publishing 2018-06-08 2018 /pmc/articles/PMC7101999/ /pubmed/29947980 http://dx.doi.org/10.1007/s00268-018-4698-3 Text en © Société Internationale de Chirurgie 2018 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Scientific Report Shirata, Chikara Hasegawa, Kiyoshi Kokudo, Takashi Yamashita, Suguru Yamamoto, Satoshi Arita, Junichi Akamatsu, Nobuhisa Kaneko, Junichi Sakamoto, Yoshihiro Kokudo, Norihiro Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction |
title | Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction |
title_full | Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction |
title_fullStr | Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction |
title_full_unstemmed | Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction |
title_short | Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction |
title_sort | liver resection for hepatocellular carcinoma in patients with renal dysfunction |
topic | Original Scientific Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101999/ https://www.ncbi.nlm.nih.gov/pubmed/29947980 http://dx.doi.org/10.1007/s00268-018-4698-3 |
work_keys_str_mv | AT shiratachikara liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction AT hasegawakiyoshi liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction AT kokudotakashi liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction AT yamashitasuguru liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction AT yamamotosatoshi liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction AT aritajunichi liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction AT akamatsunobuhisa liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction AT kanekojunichi liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction AT sakamotoyoshihiro liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction AT kokudonorihiro liverresectionforhepatocellularcarcinomainpatientswithrenaldysfunction |